Larimar Therapeutics, Inc. (LRMR) Tops Q1 EPS by 22c
Tweet
Share
E-mailGet Alerts LRMR Hot Sheet
Join SI Premium – FREE
Larimar Therapeutics, Inc. (NASDAQ: LRMR) reported Q1 EPS of ($0.31), $0.22 better than the analyst estimate of ($0.53).
For earnings history and earnings-related data on Larimar Therapeutics, Inc. (LRMR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- loanDepot receives NYSE non-compliance notice over stock price
- QSE closes $6M private placement with final tranche of $674K
- enVVeno Medical (NVNO) files $100M mixed shelf
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
